PRKDC and melanoma: We initially treated the three SPR-proficient melanoma strains in our collection with (i) 10 mM caffeine known to inhibit both ATR and ATM, or (ii) 30 μM wortmannin which inhibits ATM and DNA-PK but not ATR [31], [32] followed by exposure to IR or UV.